Literature DB >> 18777090

Regulation and privilege in transplantation tolerance.

Herman Waldmann1, Elizabeth Adams, Paul Fairchild, Stephen Cobbold.   

Abstract

BACKGROUND: There are now many ways of achieving transplantation tolerance in rodents that do not require stem cell chimerism. The best studied of these utilize short courses of antibody treatment aimed at blocking the co-receptors CD4 and CD8, and/or co-stimulatory molecules such as CD40L. Unlike tolerance through mixed chimerism which can be absolute, this form of tolerance is operational with potential effector cells remaining, but under the control of CD4 regulatory T cells (Treg). Both natural and induced CD4(+)CD25(+) FoxP3(+) Treg are involved, although other categories of Treg may also participate. Tolerated grafts can be shown to contain Treg cells, and we have proposed that they function within the graft and draining lymphoid tissue to generate a state of acquired privilege. DISCUSSION: The finding of linked suppression in tolerance suggests that Treg are drawn into microenvironments where they decommission antigen-presenting cells, and consequently perpetuate more regulation through conversion of naive T cells to regulators. Persistent antigen from accepted transplants operating within such inhibitory microenvironments provides the basis for infectious tolerance through the life of the recipient. Regulation may operate at any stage of the rejection response. Induction of tolerance appears to involve a role for the cytokine TGFbeta. This may operate both to convert naive T cells to Treg function while also subverting effector functions necessary for rejection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777090     DOI: 10.1007/s10875-008-9249-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  74 in total

1.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

Review 2.  Homeostasis and T cell regulation.

Authors:  Brigitta Stockinger; George Kassiotis; Christine Bourgeois
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

3.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients.

Authors:  Thangamani Muthukumar; Darshana Dadhania; Ruchuang Ding; Catherine Snopkowski; Rubina Naqvi; Jun B Lee; Choli Hartono; Baogui Li; Vijay K Sharma; Surya V Seshan; Sandip Kapur; Wayne W Hancock; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  Induction of tolerance in peripheral T cells with monoclonal antibodies.

Authors:  S X Qin; M Wise; S P Cobbold; L Leong; Y C Kong; J R Parnes; H Waldmann
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

5.  Induction of tolerance by monoclonal antibody therapy.

Authors:  R J Benjamin; H Waldmann
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

6.  Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.

Authors:  Andrew L Mellor; Phillip Chandler; Babak Baban; Anna M Hansen; Brendan Marshall; Jeanene Pihkala; Herman Waldmann; Stephen Cobbold; Elizabeth Adams; David H Munn
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

7.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

8.  Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation.

Authors:  Stephen F Yates; Alison M Paterson; Kathleen F Nolan; Stephen P Cobbold; Nigel J Saunders; Herman Waldmann; Paul J Fairchild
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

9.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

10.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells.

Authors:  B M Hall; M E Jelbart; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  9 in total

Review 1.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

2.  Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells.

Authors:  Gangzheng Hu; Zhongmin Liu; Changqing Zheng; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2010-08-23       Impact factor: 11.530

3.  Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.

Authors:  K Lee; V Nguyen; K-M Lee; S-M Kang; Q Tang
Journal:  Am J Transplant       Date:  2013-11-13       Impact factor: 8.086

4.  Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipients.

Authors:  Hina Shariff; Yakup Tanriver; Kathryn L Brown; Lucy Meader; Roseanna Greenlaw; Nizam Mamode; Stipo Jurcevic
Journal:  Transplantation       Date:  2010-08-15       Impact factor: 4.939

5.  CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells.

Authors:  Jian Zheng; Yinping Liu; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

6.  Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation.

Authors:  Yannick D Muller; Gang Mai; Philippe Morel; Véronique Serre-Beinier; Carmen Gonelle-Gispert; Gisella Puga Yung; Driss Ehirchiou; Jean-Christophe Wyss; Sinda Bigenzahn; Magali Irla; Christoph Heusser; Déla Golshayan; Jörg D Seebach; Thomas Wekerle; Leo H Bühler
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

Review 7.  Interpretation of transplant biopsies and immune responses following Treg cell therapy.

Authors:  Qizhi Tang; Sang-Mo Kang
Journal:  Curr Opin Organ Transplant       Date:  2014-12       Impact factor: 2.640

Review 8.  Differential sensitivity of regulatory and effector T cells to cell death: a prerequisite for transplant tolerance.

Authors:  Sylvaine You
Journal:  Front Immunol       Date:  2015-05-19       Impact factor: 7.561

9.  PARP-1 controls immunosuppressive function of regulatory T cells by destabilizing Foxp3.

Authors:  Pin Zhang; Takashi Maruyama; Joanne E Konkel; Brittany Abbatiello; Brian Zamarron; Zhao-qi Wang; Wanjun Chen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.